-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin wins French FDI clearance for Amicus merger, closing expected April 27

PUBT·04/23/2026 20:52:42
Listen to the news
BioMarin wins French FDI clearance for Amicus merger, closing expected April 27
  • BioMarin is set to acquire Amicus Therapeutics in a merger that would leave Amicus as a wholly owned subsidiary.
  • France granted foreign investment clearance for the deal on April 23, 2026.
  • That clearance satisfied the final closing condition other than items to be completed at closing.
  • Transaction is expected to close on April 27, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-173770), on April 23, 2026, and is solely responsible for the information contained therein.